Serum, cell-free, HPV-human DNA junction detection and HPV typing for predicting and monitoring cervical cancer recurrence.
- Open access
Detection of tumor-specific HPV-human DNA junctions in serum predicts cervical cancer recurrence with higher accuracy than HPV type alone.
- Why it matters: Cervical cancer caused by HPV often recurs, but current methods lack reliable non-invasive markers to predict or monitor recurrence, risking delayed intervention.
- What they did: The study analyzed serum cell-free DNA from cervical cancer patients, identifying HPV-human DNA junctions and HPV types in tumor tissue, focusing on 6-month post-treatment samples.
- The result: Presence of HPV-human DNA junctions correlated with recurrence risk, especially in cancers caused by non-α9 HPV types, enabling improved prediction and non-invasive monitoring of recurrence.